$9.37
0.00% day before yesterday
Nasdaq, Aug 30, 12:59 am CET
ISIN
US21833P1030
Symbol
CRBP

Corbus Pharmaceuticals Holdings Inc Stock price

$9.37
+0.10 1.08% 1M
+1.82 24.11% 6M
-2.43 20.59% YTD
-48.64 83.85% 1Y
+3.00 47.05% 3Y
-269.18 96.64% 5Y
-47.93 83.65% 10Y
-80.64 89.59% 20Y
Nasdaq, Closing price Fri, Aug 29 2025
-0.53 5.35%
ISIN
US21833P1030
Symbol
CRBP
Industry

Key metrics

Basic
Market capitalization
$114.8m
Enterprise Value
$-1.8m
Net debt
positive
Cash
$116.6m
Shares outstanding
12.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | 78.8
EV/Sales
- | negative
EV/FCF
0.0
P/B
1.0
Financial Health
Equity Ratio
91.4%
Return on Equity
-28.1%
ROCE
-60.0%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $1.5m
EBITDA
$-66.6m | -
EBIT
$-67.0m | $-74.0m
Net Income
$-58.0m | $-80.1m
Free Cash Flow
$-57.8m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-68.2% | -
EBIT
-66.7% | -51.0%
Net Income
-65.7% | -100.3%
Free Cash Flow
-91.6%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -5,500.0%
Free Cash Flow
-
More
EPS
$-4.7
FCF per Share
$-4.7
Short interest
12.3%
Employees
28
Rev per Employee
$0.0
Show more

Is Corbus Pharmaceuticals Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Corbus Pharmaceuticals Holdings Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Corbus Pharmaceuticals Holdings Inc forecast:

15x Buy
94%
1x Hold
6%

Analyst Opinions

16 Analysts have issued a Corbus Pharmaceuticals Holdings Inc forecast:

Buy
94%
Hold
6%

Financial data from Corbus Pharmaceuticals Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 17 17
18% 18%
-
- Research and Development Expense 50 50
93% 93%
-
-67 -67
68% 68%
-
- Depreciation and Amortization 0.42 0.42
30% 30%
-
EBIT (Operating Income) EBIT -67 -67
67% 67%
-
Net Profit -58 -58
66% 66%
-

In millions USD.

Don't miss a Thing! We will send you all news about Corbus Pharmaceuticals Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Corbus Pharmaceuticals Holdings Inc Stock News

Positive
The Motley Fool
27 days ago
Corbus (CRBP) Q2 Loss Beats Estimates
Neutral
GlobeNewsWire
2 months ago
NORWOOD, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage company focused on oncology and obesity, today announced the dosing of the first participant in the PD-1 combination arm of its Phase 1 study investigating CRB-701 in solid tumors (the Phase 1 Western study). Participants in this arm of the study a...
Neutral
GlobeNewsWire
2 months ago
NORWOOD, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fire side chat at the Piper Sandler 3rd Annual Virtual Obesity Symposium, to be held on June 26, 2025. The event will include presentations by key opinion leaders and ...
More Corbus Pharmaceuticals Holdings Inc News

Company Profile

Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. The company was founded on December 18, 2013 and is headquartered in Norwood, MA.

Head office United States
CEO Yuval Cohen
Employees 28
Founded 2009
Website www.corbuspharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today